世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000028881

新型コロナウィルス感染症(COVID-19):世界の臨床試験レビュー(2020年下半期)

GlobalData

Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H1, 2021

発刊日 2021/01/08

言語英語

体裁PDF/2066ページ

「PDF」版2066ページ

0000028881

新型コロナウィルス感染症(COVID-19):世界の臨床試験レビュー(2020年下半期)
Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H1, 2021

2,500 USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、世界の首位諸国における臨床試験件数および平均被験者数などに注目し、新型コロナウィルス感染症(COVID-19)の臨床試験の概要を提供します。また、地域別、国別(G7 & E7)、段階別、進捗状況別、臨床試験の目標の達成状況別、スポンサーの種類別に、新型コロナウィルス感染症(COVID-19)の臨床試験を分析します。さらに、臨床試験が進行中の主要薬剤の情報(進行中の臨床試験数に基づいて)を提供します。

本レポートは、GlobalData社の社内データベース(Pharma - Clinical trials database)から入手したデータを用いて作成されています。臨床試験は、世界の80を超えるさまざまな臨床試験レジストリ、会議、ジャーナル、ニュースなどから照合されています。臨床試験データベースは、ダイナミックなプロセスによって周期的に更新されます。

本レポートは意思決定能力を強化して、競争上の優位性を獲得するための効果的なカウンター戦略を作成するのに役立ちます。

注)本レポートの一部のセクションは、該当疾患におけるデータの可用性や妥当性に基づいて、削除または変更される場合があります。

■ 調査範囲

  • 世界の臨床試験の状況のスナップショットを提供します。
  • 地域別、国別(G7 & E7)、段階別、進捗状況別、スポンサーのタイプ別、および治験の目標の達成状況別に臨床試験に関するトップレベルのデータを提供します。
  • 臨床試験(試験タイトル、段階、進捗状況)に携わっている主要企業をレビューします。
  • 未完成の臨床試験(中止、保留、撤退)とその理由を提供します。
  • 過去5年間の被験者登録の傾向を提供します。
  • 過去3ヵ月の最新ニュースを提供します。

レポート詳細

目次

Table of Contents

List of Tables

List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots

Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

List of Tables
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Region, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, North America, Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2021*
Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, G7 Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, E7 Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Trial Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, by End Point Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Coronavirus Disease 2019 (COVID-19) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Region (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2021*
Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, G7 Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
Proportion of Coronavirus Disease 2019 (COVID-19) to Infectious Disease Clinical Trials, E7 Countries (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Phase (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics, Global, Clinical Trials by Trial Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, by End Point Status, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Coronavirus Disease 2019 (COVID-19) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
Coronavirus Disease 2019 (COVID-19) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
GlobalData Methodology

この商品のレポートナンバー

0000028881

TOP